331397 RESULTS
ANTIBODY polyclonal manufacturer Cat# AP12774PU-N (0.1 mg) Immunogen = synthetic phosphopeptide corresp. to aa residues surrounding Ser1033 of human MAP3K5, conj. to KLH liquid, PBS, azide, affinity purified detects MAP3K5 pSer1033 Ig ASK1/MAP3K5 Acris Antibodies
ANTIBODY polyclonal manufacturer Cat# AP08417PU-N (50 µl)<br /> No shipping to USA/Canada immunogen = partial recombinant protein (C-terminal) liquid, PBS, glycerol, azide, affinity purified recognizes MAP Kinase Kinase Kinase 5 (MEKK5/ASK1/MAP3K5) IgG ASK1/
ANTIBODY polyclonal manufacturer Cat# AP06018PU-N (100 µg) liquid, PBS, azide, affinity purified detects endogenous levels of ASK1 protein. IgG ASK1/MAP3K5 Acris Antibodies Rabbit Human Mouse ASK1 http://alzforum.org/res/com/ant/default.asp?antibodyID=35789
ANTIBODY polyclonal manufacturer Cat# AP06017PU-N (100 µg) liquid, PBS, azide, affinity purified detects endogenous levels of ASK1 protein. IgG ASK1/MAP3K5 Acris Antibodies Rabbit Human ASK1 http://alzforum.org/res/com/ant/default.asp?antibodyID=35788
ANTIBODY polyclonal manufacturer Cat# AP05790PU-N (0.1 mg) Immunogen = peptide corresp. to aa near the C-terminus of human ASK1 liquid, PBS, azide, affinity purified recognises ASK1 (Apoptosis signal-regulating kinase 1) a 155kDa protein belonging to the protein k
ANTIBODY polyclonal manufacturer Cat# AP05632PU-N (50µg) Immunogen = peptide corresp. to aa76-87 of human ASK-1 protein conj. to KLH liquid, PBS, azide, purified detects Apoptosis Signal-regulating Kinase 1 (ASK1) phosphorylated at serine83. Akt in conjunction to
PAPER Armon C
COMMENT Alzheimer's Tests: A Research Tool Not Ready for Clinical Use In July, panels sponsored jointly by the National Institute of Aging and the Alzheimer's Association presented controversial proposed guidelines for diagnosing Alzheimer's at thr
ANTIBODY polyclonal manufacturer Cat# 182 003 Immunogen = recombinant protein of mouse GluA 1 (C-terminus; aa 828- 906). affinity purified IgG, PBS, rabbit serum albumin was added for stabilization, lyophilized<br />Also available as monoclonal mouse, 182011
COMMENT I have studied Alzheimer disease (AD) since 1978, and since about 1980, I have seen some new ideas for treating AD nearly every month. Of these, five have been FDA approved and have modest benefits for patients (some improvement in cognition and behavior,
COMMENT This interesting study from Hui Zheng’s lab shows that the cytosolic APP C-terminal domain is important for neuromuscular junction (NMJ) development and postnatal viability, but has no impact on brain β amyloid generation or deposition. To address the rol
COMMENT This is a nice and quite systematic study of the long-standing question, What protease is responsible for the physiological α-secretase in neurons? Together with our previously published work (Jorissen et al., 2010) using conditionally targeted ADAM10 pri
COMMENT Few would disagree with the view that knowing the cause of a disease greatly enhances the prospect of designing effective therapies. Antibiotics for specific infectious agents are one obvious example. Recognizing the presence of dementia is rarely a probl
COMMENT The effects of BDNF on neuronal protection and synapse preservation are most impressive, similar to those shown by NGF. As they do not cross the blood-brain barrier (BBB), new methods are tested, such as the stem cell injection or genetic vector transfer
ANTIBODY monoclonal 160E5 manufacturer Cat# 182 011<br />Reference: <br /><a href="/papers/altered-histone-acetylation-associated-age-dependent-memory-impairment-mice" target="_new">Peleg, 2010</a> Immunogen = synthetic
No filters selected
